Showing results (491-500 of 546) with videos related to
Sort By:
Pageof 55
Human Molecular Genetics|April 1, 1993
Alternative splicing in the fragile X gene FMR1A J Verkerk, E de Graaff, K De Boulle, et al.The American Review of Respiratory Disease|September 1, 1989
Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantationE C Lawrence, V A Holland, J B Young, et al.Arthritis and Rheumatism|August 1, 1994
Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex regionL A Rubin, C I Amos, J A Wade, et al.Acta Crystallographica. Section C, Crystal Structure Communications|November 8, 2006
Dichloro(4,10-dimethyl-1,4,7,10-tetraazabicyclo[5.5.2]tetradecane)iron(III) hexafluorophosphateJames M McClain, Danny L Maples, Randall D Maples, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivityM M Foreman, R W Fuller, K Rasmussen, et al.American Journal of Medical Genetics|April 1, 1992
Intragenic probe used for diagnostics in fragile X familiesA J Verkerk, B B deVries, M F Niermeijer, et al.Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 1994
Fragile X syndrome in a normal IQ male with learning and emotional problemsS A Merenstein, V Shyu, W E Sobesky, et al.Human Molecular Genetics|October 9, 2001
A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutationsS Aradhya, H Woffendin, T Jakins, et al.Experimental Cell Research|December 8, 2006
Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutationJ R Brouwer, E J Mientjes, C E Bakker, et al.Science Advances|May 8, 2026
Biogenesis and downstream effects of 3',5' and 2',3' cAMP isomers in plantsMingyue Li, Monika Chodasiewicz, Malavika Muraleedharan, et al.Pageof 55